The T61 human breast cancer xenograft: An experimental model of estrogen therapy of breast cancer

This publication has 20 references indexed in Scilit:

• Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II)
  European Journal Of Cancer, 1993
• Overview From the International Conference on Long-Term Tamoxifen Therapy for Breast Cancer
  JNCI Journal of the National Cancer Institute, 1992
• Cardiovascular and all‐cause mortality in prostatic cancer patients treated with estrogens or orchiectomy as compared to the standard population
  The Prostate, 1991
• Estrogen therapy and liver function—metabolic effects of oral and parenteral administration
  The Prostate, 1989
• Cardiovascular follow‐up of patients with prostatic cancer treated with single‐drug polyestradiol phosphate
  The Prostate, 1987
• Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens
  Biochemical and Biophysical Research Communications, 1987
• Effect of tamoxifen on the receptor-positive T61 and the receptor-negative T60 human breast carcinomas grown in nude mice
  European Journal of Cancer and Clinical Oncology, 1985
• Characterization of the T61 human breast carcinoma established in nude mice
  European Journal of Cancer and Clinical Oncology, 1985
• Dose-Dependent Effect of 17β-Estradiol Determined by Growth Curves and Flow Cytometric DNA Analysis of a Human Breast Carcinoma (T61) Grown in Nude Mice
  Pathobiology, 1985
• Randomized Clinical Trial of Diethylstilbestrol versus Tamoxifen in Postmenopausal Women with Advanced Breast Cancer
  New England Journal of Medicine, 1981